generic
FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis
October 7, 2020Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis
Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …
Mylan secures first FDA approval for generic version of Biogen’s Tecfidera following patent dispute
August 20, 2020Sales and Marketing Biogen, FDA, Mylan, generic, tecfidera
The FDA has approved its first generic of Biogen’s multiple sclerosis (MS) treatment Tecfidera, awarding authorisation to Mylan which is …
Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India
July 20, 2020Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir
Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …
FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload
January 7, 2020Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma
Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …
FDA approve valsartan generic after shortages of supply
March 13, 2019Manufacturing and Production, Research and Development FDA, blood pressure drugs, cardiovascular, generic, valsartan
The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply …
Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler
January 31, 2019Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma
Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
US court overturns J&J’s Zytiga patent in combination with prednisone
October 29, 2018Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone
A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …
Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic
March 12, 2018Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma
Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …
Servier fights fine over antitrust breaches
June 7, 2017Manufacturing and Production, Research and Development, Sales and Marketing European Commission, Servier, generic
Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …
Glenmark greenlighted to market hypertension generic in US
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension
Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
Teva hit by patent blow upon top-selling MS drug
January 31, 2017Manufacturing and Production Mylan, Teva, generic, multiple sclerosis
Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …
FDA approves Dechra’s generic antibiotic
September 9, 2016Medical Communications, Sales and Marketing Dechra, Putney, antiobiotic, generic
Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …
Allergan launches Crestor generic in the US
May 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales
Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …
Mylan launches new dosages of generic of Novartis hypertension drug in US
April 11, 2016Manufacturing and Production Mylan, Novartis, generic, high blood pressure, hypertension
Mylan (TASE: MYL) has announced the US launch of new dosages of its generic version of Novartis’s hypertension drug, Lopressor …
Mylan launches generic of Valeant’s Ultram in the US
March 29, 2016Manufacturing and Production, Sales and Marketing FDA, Mylan, Valeant, abbreviate new drug application, generic, pain, tramadol, ultram
Mylan (NASDAQ, TASE: MYL) has announced the launch of its generic version of Valeant’s Ultram tablets in the US. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
